Press Room
  Date Title View
Mar 30, 2016
FOSTER CITY, Calif., March 30, 2016 /PRNewswire/-- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Wilson W. Cheung, Chief Financial Officer, will present a corporate overview and business update at the 15th Annual Needham Healthcare Conference at 8:00 am ET on Wednesday, April 13, 2016, at the Westin Grand Central Hotel in New Y...
PDF
Mar 10, 2016
FOSTER CITY, Calif., March 10, 2016 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter and year ended December 31, 2015. Revenues: Revenues for the full year 2015 were $157.3 million, compared to $134.8 million for the full year of 2014. In the fourth quarter of 2015, revenues w...
PDF
Feb 22, 2016
FOSTER CITY, Calif., Feb. 22, 2016 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the fourth quarter and full year 2015 on Thursday, March 10, 2016. SciClone will host a conference call and webcast to provide a business and product update at 4:30 pm ET (1:30 pm PT) that da...
PDF
Feb 4, 2016
FOSTER CITY, Calif., Feb. 4, 2016 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) (the "Company") today announced it has entered into a settlement agreement with the United States Securities and Exchange Commission (SEC) fully resolving the SEC's investigation into possible violations of the Foreign Corrupt Practices Act (FCPA).  Unde...
PDF
Jan 27, 2016
FOSTER CITY, Calif., Jan. 27, 2016 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview and business update at the 18th Annual BIO CEO & Investor Conference at 8:30 am ET on Tuesday, February 9, 2016, at the Waldorf Astoria Hotel in New...
PDF
Jan 11, 2016
FOSTER CITY, Calif., Jan. 11, 2016 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced its preliminary 2015 revenue results, and that it has achieved its revenue expectations for 2015. For 2015, the Company expects 2015 sales revenues of between $157 and $158 million, which are at the high end of the guidance o...
PDF
Dec 21, 2015
FOSTER CITY, Calif., Dec. 21, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced plans to pursue development and registration of SGX942 in the Greater China market, for the treatment of oral mucositis. SGX942 is being developed by Soligenix, Inc. (OTCQB: SNGX), which recently reported positive preliminary results fro...
PDF
Nov 17, 2015
FOSTER CITY, Calif., Nov. 17, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview and business update at the 27th Annual Piper Jaffray Healthcare Conference at 10:30 am ET on Wednesday, December 2, 2015, at the New York Palace Hotel...
PDF
Nov 9, 2015
FOSTER CITY, Calif., Nov. 9, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended September 30, 2015. Revenues: In the third quarter of 2015, SciClone reported revenues of $42.9 million, compared to $34.3 million for the same period in 2014.  GAAP Diluted EPS: I...
PDF
Nov 3, 2015
FOSTER CITY, Calif., Nov. 3, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will participate in a panel discussion at the Boston Biotech Conferences (BBC) NY/NJ CEO conference on November 12th, at the Apella in New York City. The conference will foc...
PDF
FirstPrevious
3
...
NextLast